Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.

Ouillette P, Collins R, Shakhan S, Li J, Li C, Shedden K, Malek SN.

Clin Cancer Res. 2011 Nov 1;17(21):6778-90. doi: 10.1158/1078-0432.CCR-11-0785. Epub 2011 Sep 2.

2.

Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.

Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN.

Cancer Res. 2008 Feb 15;68(4):1012-21. doi: 10.1158/0008-5472.CAN-07-3105.

3.

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.

Dal Bo M, Rossi FM, Rossi D, Deambrogi C, Bertoni F, Del Giudice I, Palumbo G, Nanni M, Rinaldi A, Kwee I, Tissino E, Corradini G, Gozzetti A, Cencini E, Ladetto M, Coletta AM, Luciano F, Bulian P, Pozzato G, Laurenti L, Forconi F, Di Raimondo F, Marasca R, Del Poeta G, Gaidano G, Foà R, Guarini A, Gattei V.

Genes Chromosomes Cancer. 2011 Aug;50(8):633-43. doi: 10.1002/gcc.20885. Epub 2011 May 11.

PMID:
21563234
4.

Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus.

Liu Y, Szekely L, Grandér D, Söderhäll S, Juliusson G, Gahrton G, Linder S, Einhorn S.

Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8697-701.

5.

Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.

Puiggros A, Venturas M, Salido M, Blanco G, Fernandez-Rodriguez C, Collado R, Valiente A, Ruiz-Xivillé N, Carrió A, Ortuño FJ, Luño E, Calasanz MJ, Ardanaz MT, Piñán MÁ, Talavera E, González MT, Ortega M, Marugán I, Ferrer A, Gimeno E, Bellosillo B, Delgado J, Hernández JÁ, Hernández-Rivas JM, Espinet B; Grupo Cooperativo Español de Citogenética Hematológica (GCECGH); Grupo Español de Leucemia Linfática Crónica (GELLC).

Genes Chromosomes Cancer. 2014 Sep;53(9):788-97. doi: 10.1002/gcc.22188. Epub 2014 Jun 10.

PMID:
24915757
6.

Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.

Hogan WJ, Tefferi A, Borell TJ, Jenkins R, Li CY, Witzig TE.

Cancer Genet Cytogenet. 1999 Apr 15;110(2):77-81.

PMID:
10214353
7.

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.

Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, Bastard C, Kawamata N, Koeffler HP.

Cancer. 2008 Mar 15;112(6):1296-305. doi: 10.1002/cncr.23270.

8.

Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.

Ouillette P, Fossum S, Parkin B, Ding L, Bockenstedt P, Al-Zoubi A, Shedden K, Malek SN.

Clin Cancer Res. 2010 Feb 1;16(3):835-47. doi: 10.1158/1078-0432.CCR-09-2534. Epub 2010 Jan 19.

9.

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.

Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R.

Blood. 2001 Apr 1;97(7):2098-104.

10.

11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.

Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P.

Blood. 1997 Apr 1;89(7):2516-22.

11.

The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia.

Starostik P, O'Brien S, Chung CY, Haidar M, Manshouri T, Kantarjian H, Freireich E, Keating M, Albitar M.

Leuk Res. 1999 Sep;23(9):795-801.

PMID:
10475618
12.

Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.

Humplikova L, Kollinerova S, Papajik T, Pikalova Z, Holzerova M, Prochazka V, Divoka M, Modriansky M, Indrak K, Jarosova M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Dec;157(4):284-93. doi: 10.5507/bp.2013.057. Epub 2013 Sep 5.

13.

Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).

Grygalewicz B, Woroniecka R, Rygier J, Borkowska K, Rzepecka I, Łukasik M, Budziłowska A, Rymkiewicz G, Błachnio K, Nowakowska B, Bartnik M, Gos M, Pieńkowska-Grela B.

Mol Cytogenet. 2016 Jan 6;9:1. doi: 10.1186/s13039-015-0212-x. eCollection 2016.

14.

Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study.

Bigoni R, Cuneo A, Roberti MG, Bardi A, Rigolin GM, Piva N, Scapoli G, Spanedda R, Negrini M, Bullrich F, Veronese ML, Croce CM, Castoldi G.

Leukemia. 1997 Nov;11(11):1933-40.

PMID:
9369429
15.

Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.

Chung CY, Kantarjian H, Haidar M, Starostik P, Manshouri T, Gidel C, Freireich E, Keating M, Albitar M.

Cancer. 2000 Mar 15;88(6):1359-64. Erratum in: Cancer. 2003 May 1;97(9):2349.

PMID:
10717617
16.

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.

Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM.

JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.

17.

Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.

Herold T, Jurinovic V, Mulaw M, Seiler T, Dufour A, Schneider S, Kakadia PM, Feuring-Buske M, Braess J, Spiekermann K, Mansmann U, Hiddemann W, Buske C, Bohlander SK.

Genes Chromosomes Cancer. 2011 Jul;50(7):546-58. doi: 10.1002/gcc.20879. Epub 2011 Apr 15.

PMID:
21500311
18.

Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.

Dickinson JD, Joshi A, Iqbal J, Sanger W, Bierman PJ, Joshi SS.

Int J Mol Med. 2006 May;17(5):769-78.

PMID:
16596259
19.

Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.

Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV.

J Mol Diagn. 2013 Mar;15(2):196-209. doi: 10.1016/j.jmoldx.2012.09.006. Epub 2012 Dec 27.

20.

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, Fisch P, Timmer J, Veelken H.

Blood. 2007 Feb 1;109(3):1202-10. Epub 2006 Oct 19.

Items per page

Supplemental Content

Write to the Help Desk